70 results on '"S. Campagne-Loiseau"'
Search Results
2. Complications after perineal surgery (with or without implantation of material): First results of the French multicenter observatory VIGIMESH after 1873 inclusions
- Author
-
T. Charles, S. Campagne-Loiseau, M. Cosson, P. Ferry, C. Saussine, J.-P. Lucot, D. Salet-Lizee, M.-L. Barussaud, T. Boisramé, C. Carlier-Guérin, P. Debodinance, X. Deffieux, A.-C. Pizzoferrato, S. Curinier, S. Ragot, V. Ringa, R. De Tayrac, A. Fauconnier, and X. Fritel
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
3. 280 SERIOUS COMPLICATIONS AND RECURRENCE AFTER STRESS URINARY INCONTINENCE SURGERY BY MID-URETHRA SLING IN THE VIGI-MESH REGISTER: DESCRIPTION AND MEDIUM-TERM INCIDENCE FOR 2683 WOMEN
- Author
-
C Armengaud, H Drioueche, S Campagne-Loiseau, R De Tayrac, C Saussine, L Panel, M Cosson, X Deffieux, P Lucot J, A Pizzoferrato, P Ferry, A Vidart, T Thubert, G Capon, P Debodinance, Y Aubard, A Koebele, J Hermieu, X Game, R Ramanah, G Lamblin, E Lecornet, A Fauconnier, and X Fritel
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Published
- 2022
- Full Text
- View/download PDF
4. 433 PERCEIVED HEALTH STATUS AFTER SUB-URETHRAL SLING REVISION, ABOUT 290 WOMEN FROM THE VIGIMESH REGISTRY.
- Author
-
H Camilli, B Fatton, E Gand, S Campagne-Loiseau, R De Tayrac, L Wagner, C Saussine, J Rigaud, T Thubert, X Deffieux, M Cosson, P Ferry, A Pizzoferrato, G Capon, L Panel, E Chartier-Kastler, A Fauconnier, T Gauthier, X Game, C Bouynat, A Zimolong, and X Fritel
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Published
- 2022
- Full Text
- View/download PDF
5. Instillations endovésicales pour les cystopathies chroniques inflammatoires et douloureuses : revue de la littérature et guide de la pratique clinique
- Author
-
F. Meyer, É. Chen, N. Berrogain, P.O. Bosset, S. Campagne-Loiseau, V. Cardot, T. Charles, X. Deffieux, L. Donon, L. Even, F. Girard, J.-F. Hermieu, S. Hurel, J. Klap, L. Peyrat, C. Thuillier, B. Tibi, A. Vidart, L. Wagner, and J.-N. Cornu
- Subjects
Urology - Published
- 2022
6. 2021 opinion from the CUROPF on THE efficacy and safety of mid-urethral slings used in women WITH urinary stress incontinence
- Author
-
V, Cardot, S, Campagne-Loiseau, P, Roulette, L, Peyrat, A, Vidart, L, Wagner, C, Thuillier, J, Klap, S, Hurel, J F, Hermieu, F, Girard, L, Even, L, Donon, T, Charles, B, Tibi, P O, Bosset, N, Berrogain, F, Meyer, J-N, Cornu, and X, Deffieux
- Subjects
Male ,Suburethral Slings ,Treatment Outcome ,Urethra ,Urinary Incontinence, Stress ,Urology ,Urethral Diseases ,Humans ,Urologic Surgical Procedures ,Female ,Aged - Abstract
To determine the usefulness of mid-urethral slings (MUS) in the surgical management of women presenting with urinary stress incontinence (USI) METHOD: A consensus committee of multidisciplinary experts (CUROPF) was convened and focused on PICO questions concerning the efficacy and safety of MUS surgery compared to other procedures and concerning which approach (retropubic (RP) vs transobturator (TO)) should be proposed as a first-line MUS surgery for specific subpopulations (obese; intrinsic sphincteric deficiency (ISD); elderly) RESULTS: As compared to other procedures (urethral bulking agents, traditional slings and open colposuspension), the MUS procedure should be proposed as the first-line surgical therapy (strong agreement). MUS surgery can be associated with complications and proper pre-operative informed consent is mandatory (strong agreement). Mini-slings (SIS/SIMS) should only be proposed in clinical trials (strong agreement). Both RP and TO approaches may be proposed for the insertion of MUS (strong agreement). However, if the woman is willing to accept a moderate increase in per-operative risk, the RP approach should be preferred (strong agreement) since it is associated with higher very long-term cure rates and as it is possible to completely remove the sling surgically if a severe complication occurs. The RP approach should be used for the insertion of MUS in a woman presenting with ISD (strong agreement). Either the RP or TO approach should be used for the insertion of MUS in an obese woman presenting with USI (strong agreement). In very obese women (BMI ≥35-40kg/m
- Published
- 2022
7. Complications des bandelettes sous urétrales : une revue de la littérature par le Comité d’urologie et pelvipérinéologie de la femme de l’Association française d’urologie
- Author
-
C. Thuillier, F. Meyer, L. Even, T. Charles, I. Bentellis, A. Vidart, L. Peyrat, J.-F. Hermieu, P. Treacy, Laurent Wagner, P.O. Bosset, X. Deffieux, J. Klap, N. Berrogain, L. Donon, S. Hurel, Jean-Nicolas Cornu, S. Campagne-Loiseau, Brannwel Tibi, F. Girard, and V. Cardot
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Urology ,medicine ,business - Abstract
Resume Introduction La mise en place d’une bandelette sous-uretrale est le gold standard dans la prise en charge chirurgicale de l’incontinence urinaire d’effort de la femme en France. L’efficacite de ce materiel n’est plus a demontrer mais les complications per- et postoperatoires font l’objet a l’heure actuelle d’une controverse importante en Europe mais egalement outre-Manche et outre-Atlantique ayant conduit a la modification des indications operatoires. En France, la reglementation evolue egalement avec un encadrement plus strict des indications operatoires par RCP et une obligation de suivi postoperatoire a court, moyen et long terme. Objectifs Dans ce contexte, le CUROPF a entrepris de realiser une revue de la litterature rassemblant les preuves scientifiques disponibles concernant la survenue de complications per- et postoperatoires relatives a la pose de BSU. Materiel et methode La recherche bibliographique a ete realisee a partir de la base de donnees Medline et 123 articles ont ete retenus. Resultats L’analyse des donnees met en evidence des complications variees, dependantes du materiel implante, du terrain initial et de l’indication operatoire. La bandelette sous-uretrale retro-pubienne est pourvoyeuse de plus d’effraction vesicale peroperatoire (jusqu’a 14 %), plus de douleurs sus pubiennes (4 %) et plus de retention aigue d’urine et dysurie en postoperatoire (jusqu’a respectivement 19,7 % et 26 %). La bandelette sous-uretrale trans obturatrice est responsable de plus d’effraction vaginale peroperatoire (10,9 %), plus de douleur de membre inferieur d’origine neurologique (jusqu’a 26,7 %). Le risque de survenue d’un syndrome d’HAV est similaire dans les 2 voies d’abord (33 %). Mais ces risques de complications sont a ponderer par un fort impact de la chirurgie de l’incontinence urinaire sur l’amelioration de la qualite de vie globale de ces femmes. Conclusion Ainsi la connaissance de ces risques ne doit pas limiter l’indication de la prise en charge de l’incontinence urinaire d’effort par la pose de la BSU mais doit permettre de ponderer les indications operatoires en fonction du terrain, d’informer les patientes de maniere eclairee et les surveiller etroitement sur long terme.
- Published
- 2021
8. Utilisation du LASER vaginal pour le traitement des pathologies génito-urinaires : revue systématique de la littérature et position du CUROPF
- Author
-
Laurent Wagner, P.O. Bosset, L. Peyrat, A. Vidart, C. Thuillier, P. Roulette, Jean-Nicolas Cornu, J.-F. Hermieu, J. Klap, L. Donon, X. Deffieux, N. Berrogain, S. Campagne-Loiseau, Brannwel Tibi, F. Girard, V. Cardot, and T. Charles
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Laser therapy ,business.industry ,Urology ,030232 urology & nephrology ,Medicine ,Female urology ,business - Abstract
Resume Introduction Le traitement par LASER vaginal est une option therapeutique d’utilisation croissante en urogynecologie, mais son interet reste debattu. L’objectif de cette revue etait d’etablir les donnees de la litterature et d’en produire une analyse critique. Methodes Une revue systematique de la litterature a ete conduite jusque mars 2020 en utilisant les bases de donnees PubMed, Medline, Cochrane et Embase, pour identifier les etudes ayant utilise le LASER dans le domaine de l’urogynecologie. Resultats Quarante etudes ont ete inclues dans l’analyse (8 concernant le syndrome genito-urinaire de la menopause (SGUM), 19 pour l’incontinence urinaire a l’effort (IUE), 3 pour l’hyperactivite vesicale (HAV), 7 pour le prolapsus genital (POP), 3 pour d’autres indications). Les donnees etaient heterogenes, de niveau de preuve faible a tres faible. Une minorite etait comparative, et seules trois etaient randomisees. Les donnees etaient en faveur d’une efficacite modeste du LASER dans le traitement du SGUM, de l’incontinence, de l’HAV et du prolapsus a court terme sur les symptomes, la satisfaction et la qualite de vie. Peu d’effets secondaires ont ete rapportes. Cependant, des risques de biais methodologiques majeurs ont ete notes concernant l’evaluation de l’efficacite et de la securite. Aucune etude n’etait disponible a long terme. Conclusions Bien que le LASER semble montrer des resultats encourageants, le niveau de preuve de son efficacite et de sa securite d’emploi (notamment a long terme) etait faible. Des etudes de meilleure qualite apparaissaient donc necessaires, avant une hypothetique recommandation de son utilisation hors du champ de la recherche clinique.
- Published
- 2021
9. Réunion de concertation pluridisciplinaire en pelvi-périnéologie en France : résultats d’une enquête nationale auprès des urologues français
- Author
-
H. Dupuis, N. Berrogain, P. Bosset, S. Campagne-Loiseau, V. Cardot, T. Charles, X. Deffieux, L. Donon, F. Girard, J. Hermieu, J. Klap, S. Hurel, B. Tibi, L. Even, F. Meyer, C. Thuillier, A. Vidart, L. Wagner, B. Peyronnet, and J.-N. Cornu
- Subjects
Urology - Published
- 2022
10. État de santé perçu des femmes après reprise chirurgicale de bandelette sous-urétrale : à propos de 282 femmes
- Author
-
H. Camilli, B. Fatton, E. Gand, E. Chartier-Kastler, S. Campagne-Loiseau, R. De Tayrac, L. Wagner, C. Saussine, J. Rigaud, T. Thubert, X. Deffieux, M. Cosson, P. Ferry, A. Pizzoferrato, G. Capon, L. Panel, A. Faucaonnier, T. Gauthier, X. Game, and X. Fritel
- Subjects
Urology - Published
- 2022
11. Serious complications and recurrences after pelvic organ prolapse surgery for 2309 women in the VIGI‐MESH registry
- Author
-
X Fritel, R Tayrac, J Keizer, S Campagne‐Loiseau, M Cosson, P Ferry, X Deffieux, J‐P Lucot, L Wagner, P Debodinance, C Saussine, A‐C Pizzoferrato, C Carlier‐Guérin, T Thubert, L Panel, P‐O Bosset, E Nkounkou, R Ramanah, T Boisramé, T Charles, C Raiffort, A Charvériat, S Ragot, A Fauconnier, Adnan Aboukassem, Chérif Akladios, Emmanuelle Arsène, Jean‐Sébastien Aucouturier, Georges Bader, Emmanuel Bailly, Jean‐Jacques Baldauf, Stéphanie Bartolo, Marie‐Line Barussaud, Fanny Béchard, Simon Bernardeau, Clément Biscans, Deepak Boodhun, Revaz Botchorishvili, Michel Boukaram, Aude Brams, Laurent Bressler, Clément Bruhat, Michel Canis, Victor Cavillon, Olivier Celhay, Armand Chevrot, Pierre Collinet, Arnaud Cornille, Pierre Costa, Christophe Courtieu, Laurent Courtois, Sandra Curinier, Eric Darnis, Pierre‐Olivier Delpech, Véronique Delporte, Anne Dubois, Emilie Faller, Brigitte Fatton, Cécile Féyeux, Victor Gabriele, Pierre Gadonneix, Olivier Garbin, Florent Genty, Géraldine Giraudet, Pascale Gres, Pauline Gueudry, Jean‐François Haab, Audrey Hedde, Aline Host, Michel Hummel, Estelle Jean dit Gautier, Aminata Kane, Sophie Gouic, Isabelle Teuff, Gil Lebreton, Lise Lecointre, Grégoire Léon, Yolande Maisonnette, Lucile Martin, Aurore Marx, Pascal Mouracade, Corinne Palamara, Petit Nicolas, Caroline Pettenati, Laurence Peyrat, Pierre Pillot, Jean‐Luc Pouly, Clothilde Poupon, Michel Prudhomme, Benoît Rabishong, Hélène Ricard, Jérémie Ripoche, Géraldine Rivaux, Jennifer Salerno, Delphine Salet‐Lizée, Richard Sarfati, Maxence Sarradin, Elodie Schuller, An Segaert, François Stoll, Yannick Thirouard, Caroline Trichot, Mélusine Turck, David Vandendriessche, Edouard Vaucel, Sarah Vieillefosse, Anne Villot, Denis Vinatier, Etienne Vincens, Marie Vinchant, Béatrice Vinson‐Bonnet, Soraya Wapler, Sophie Warembourg, CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, CHU Lille, Hôpital Saint-Louis de La Rochelle (CH La Rochelle), AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Saint Vincent de Paul de Lille, Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL), Université catholique de Lille (UCL)-Université catholique de Lille (UCL), CH Dunkerque, CHU Strasbourg, CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), CH de Châtellerault, Centre hospitalier universitaire de Nantes (CHU Nantes), Clinique Beau Soleil [Montpellier], Hôpital Foch [Suresnes], Centre Hospitalier de Béthune (CH Béthune), GHT de l'Artois, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Groupe Hospitalier Diaconesses Croix Saint-Simon, Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS [Poissy], Fritel, Xavier, Groupe Hospitalier de l'Institut Catholique de Lille (GHICL), and centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS [Poissy]
- Subjects
Reoperation ,medicine.medical_specialty ,Multivariate analysis ,[SDV]Life Sciences [q-bio] ,Population ,registry ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,Risk profile ,03 medical and health sciences ,Gynecologic Surgical Procedures ,Postoperative Complications ,0302 clinical medicine ,surgical complication ,Recurrence ,Risk Factors ,Humans ,Medicine ,Prospective Studies ,Registries ,030212 general & internal medicine ,education ,Prospective cohort study ,Aged ,Pelvic organ ,education.field_of_study ,030219 obstetrics & reproductive medicine ,business.industry ,Prolapse surgery ,Incidence (epidemiology) ,Hazard ratio ,Obstetrics and Gynecology ,Middle Aged ,Surgical Mesh ,Vaginal repair ,pelvic organ prolapse ,Confidence interval ,3. Good health ,Surgery ,[SDV] Life Sciences [q-bio] ,[SDV.MHEP.GEO] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,mesh ,Vagina ,Female ,Laparoscopy ,Longitudinal study ,business - Abstract
Objective To assess the incidence of serious complications and reoperations for recurrence after surgery for pelvic organ prolapse (POP) and compare the three most common types of repair. Design Prospective cohort study using a registry. Setting Nineteen French surgical centres. Population A total of 2309 women participated between 2017 and 2019. Methods A multivariate analysis including an inverse probability of treatment weighting approach was used to obtain three comparable groups. Main outcome measures Serious complications and subsequent reoperations for POP recurrence. Results The median follow-up time was 17.6 months. Surgeries were native tissue vaginal repairs (n = 504), transvaginal mesh placements (n = 692) and laparoscopic sacropexies with mesh (n = 1113). Serious complications occurred among 52 women (2.3%), and reoperation for POP recurrence was required for 32 women (1.4%). At 1 year the cumulative weighted incidence of serious complications was 1.8% for native tissue vaginal repair, 3.9% for transvaginal mesh and 2.2% for sacropexy, and the rates for reoperation for recurrence of POP were 1.5, 0.7 and 1.1%, respectively. Compared with native tissue vaginal repair, the risk of serious complications was higher in the transvaginal mesh group (weighted hazard ratio, wHR 3.84, 95% CI 2.43-6.08) and the sacropexy group (wHR 2.48, 95% CI 1.45-4.23), whereas the risk of reoperation for prolapse recurrence was lower in both the transvaginal mesh (wHR 0.22, 95% CI 0.13-0.39) and sacropexy (wHR 0.29, 95% CI 0.18-0.47) groups. Conclusions Our results suggest that native tissue vaginal repairs have the lowest risk of serious complications but the highest risk of reoperation for recurrence. These results are useful for informing women and for shared decision making. Tweetable abstract Laparoscopic sacropexy had fewer serious complications than transvaginal mesh and fewer reoperations for recurrence than vaginal repair.
- Published
- 2021
12. [Complications of mid-urethral sling - A review from the Committee for Female Urology and Pelviperineology for the French Association of Urology]
- Author
-
L, Even, B, Tibi, I, Bentellis, P J, Treacy, N, Berrogain, P O, Bosset, S, Campagne-Loiseau, V, Cardot, T, Charles, X, Deffieux, L, Donon, F, Girard, J-F, Hermieu, S, Hurel, J, Klap, F, Meyer, L, Peyrat, C, Thuillier, A, Vidart, L, Wagner, and J N, Cornu
- Subjects
Suburethral Slings ,Treatment Outcome ,Urinary Incontinence, Stress ,Urology ,Quality of Life ,Humans ,Urologic Surgical Procedures ,Female - Abstract
Placement of a mid-urethral sling is the gold standard in the surgical management of stress urinary incontinence in women in France. The cure rate of this material is no longer to be demonstrated, but the per- and post-operative complications are currently the subject of a growing controversy not only in Europe but also across the Channel and across the Atlantic, having led to the modification of operative indications. In France, recommendations are also evolving with a stricter framework for indications for surgery by multidisciplinary consultation meeting and an obligation for postoperative follow-up in the short and long term.In this context, CUROPF realized a review of the literature bringing together the available scientific evidence concerning the occurrence of per- and post-operative complications relating to the installation of mid urethral sling. The bibliographic search was carried out using the Medline database and 123 articles were selected.Analysis of the data highlights various complications, depending on the implanted material, the patient and the indication for surgery. The retro-pubic mid urethral sling provides more bladder erosion during surgery (up to 14%), more suprapubic pain (up to 4%) and more acute urinary retention (up to 19,7%) and postoperative dysuria (up to 26%). The trans obturator mid-urethral sling is responsible for more vaginal erosion during the operation (up to 10,9%), more lower limb pain of neurological origin (up to 26,7%). The risk of developing over active bladder is similar in both procedures (up to 33%). But these risks of complications must be balanced by the strong impact of urinary incontinence surgery on the overall quality of life of these women.Thus, surgical failure and long term complications exist but should not limit the surgical management of stress urinary incontinence with mid urethral tape. Women should be treated with individualized decision-making process and long-term follow -up is necessary.
- Published
- 2021
13. Serious complications and recurrences after pelvic organ prolapse surgery for 2,309 women in the VIGI-MESH registry
- Author
-
L. Panel, Philippe Debodinance, A. Chavériat, S. Campagne-Loiseau, R de Tayrac, Xavier Fritel, Thomas Boisramé, Laurent Wagner, C. Carlier-Guérin, J.-P. Lucot, P.O. Bosset, Thibault Thubert, Arnaud Fauconnier, Christian Saussine, A-C Pizzoferrato, Cyril Raiffort, E. Nkounkou, P. Ferry, X. Deffieux, R. Ramanah, Michel Cosson, and T. Charles
- Subjects
medicine.medical_specialty ,Pelvic organ ,business.industry ,Urology ,Prolapse surgery ,Medicine ,business ,Surgery - Published
- 2021
14. Complications, révisions et qualité de vie à moyen terme après 1 814 chirurgies de l’incontinence urinaire d’effort par bandelette sous-urétrale : données du registre VIGI-MESH
- Author
-
T. Charles, A.C. Pizzoferrato, L. Panel, Christian Saussine, R. Ramanah, Michel Cosson, C. Carlier, Arnaud Fauconnier, T. Hubert, E. Nkounkou, P. Ferry, S. Campagne-Loiseau, Philippe Debodinance, Xavier Fritel, Laurent Wagner, X. Deffieux, R. de Tayrac, Michel Hummel, A. Vidart, J.-P. Lucot, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, CH La Rochelle, CHU Strasbourg, CHU Lille, AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de santé de la 32 ème, Hôpital Saint Vincent de Paul de Lille, Groupe Hospitalier de l'Institut Catholique de Lille (GHICL), CH Dunkerque, CH de Châtellerault, Service d'Urologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Hôpital Foch [Suresnes], Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre Hospitalier de Béthune (CH Béthune), GHT de l'Artois, and centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS [Poissy]
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Urology ,030232 urology & nephrology ,Medicine ,[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery ,business ,[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology ,3. Good health - Abstract
International audience; Objectifs : la chirurgie de l’incontinence urinaire d’effort (IUE) par bandelettes sous-urétrales (BSU) fait l’objet d’essais cliniques limités en taille, rapportant peu les complications rares et la qualité de vie (QdV). Les registres permettent de rapporter ces complications rares dans la pratique courante et de mesurer la QdV globale, du point du vue des troubles urinaires et pelviens.Méthodes : l’objectif du registre VIGI-MESH est de spécifier l’incidence de ces complications rares et graves en fonction des différents types de BSU (rétropubiennes, transobturatrices, à incision unique/mini-bandelettes) ainsi que de mesurer cette QdV après la pose de BSU. Entre février 2017 et novembre 2019, chaque chirurgie initiale ou de reprise de BSU dans un des 18 centres participants était colligée sur un formulaire par le chirurgien. Un contrôle était effectué à partir des pharmacies délivrant les dispositifs médicaux implantés et des actes codés par les centres participants. Un questionnaire recherchant une complication était envoyé à toutes les patientes à un an. Il comportait également des questions validées en français sur le bien-être ressenti et l’amélioration des symptômes (WHO, European Quality of life Questionnaire 5 Dimensions [EQ5D], Patient Global Impression of Improvement [PGI-I]) Les complications ont été gradées selon la classification de Clavien–Dindo : arrêt de l’intervention sans pose de matériel (grade III), intervention chirurgicale ultérieure secondaire à une complication (grade III), complication menaçant la vie (grade IV), décès de la patiente (grade V).Résultats : quatre-vingt-deux patientes ont eu des complications de grade ≥ III : 5,7 % (53/923) voie rétropubienne, 4,0 % (21/521) voie transobturatrice et 2,2 % (8/370) mini-bandelette. Dix complications peropératoires ont empêché la pose de BSU. La BSU a été desserrée dans les 48 h dans 6 cas. Le risque de complication était 3 fois plus faible avec une mini-bandellette par rapport à une BSU rétropubienne (RR = 0,36 [0,170,75]), le risque n’était pas significativement différent entre les approches transobturatrice et rétropubienne (RR = 0,67 [0,40–1,11]). Vingt-sept femmes (1,5 %) ont eu une reprise chirurgicale pour échec ou récidive, 15 après BSU rétropubienne (1,6 %), 7 après bandelette transobturatrice (1,4 %) et 5 après mini-bandelette (1,4 % ; p = 0,95) (Fig. 1). La procédure a consisté à retendre la BSU (9 cas), injection de Bulkamid® (2 cas) et mise en place d’une seconde BSU (16 cas). Parmi les 1167 patientes contactées par courrier, 692 réponses (59,3 %) ont été retournées à un an ou plus après la chirurgie. À la question « Que pensez-vous de votre état de santé actuel par rapport à ce qu’il était avant votre chirurgie pour incontinence ou prolapsus ? » 91,4 % (608/665) se sentaient mieux (beaucoup mieux, mieux ou un peu mieux) (PGI-I). L’amélioration ressentie était meilleure en l’absence de complications graves ≥ III (p = 0,008). Parmi les patientes, 96,2 % (630/655) ont évalué leur état de santé général comme étant bon (très bon, bon ou assez bon). L’état de santé général ressenti était similaire qu’elles aient eu ou non des complications. Par rapport à la population française du même âge, les patientes opérées d’une BSU ont déclaré avoir un meilleur état de la santé.Conclusion : les premiers résultats du registre VIGI-MESH montrent que les mini-bandelettes sont une option thérapeutique avec une efficacité à moyen terme similaire aux voies rétropubiennes et transobturatrices avec moins de complications. Ils montrent également que plus de 90 % des patientes rapportent avoir été améliorées par la mise en place d’une BSU pour IUE. Le ressenti de l’état de santé global des patientes opérées était meilleur que celui de la population française féminine du même âge. Néanmoins, une analyse à plus long terme est nécessaire pour confirmer ces premiers résultats.
- Published
- 2020
15. [Vaginal LASER therapy for genito-urinary disorders: A systematic review and statement from the Committee for Female Urology and Pelviperineology of the French Association of Urology]
- Author
-
J, Klap, S, Campagne-Loiseau, N, Berrogain, P O, Bosset, V, Cardot, T, Charles, X, Deffieux, L, Donon, F, Girard, L, Peyrat, P, Roulette, C, Thuillier, B, Tibi, A, Vidart, L, Wagner, J-F, Hermieu, and J-N, Cornu
- Subjects
Lasers ,Urinary Incontinence, Stress ,Urology ,Vagina ,Quality of Life ,Humans ,Female ,Laser Therapy - Abstract
Vaginal LASER therapy is increasingly used in the field of urogynecology, but several points remain unclear. Our goal was to produce a systematic review of available evidence and provide a critical appraisal of available data.A systematic review until march 2020 was conducted using PubMed/MEDLINE, Cochrane and Embase databases. All studies about vaginal LASER use in the field of urogynecology were included.Forty studies have been included (8 for genitourinary syndrome of menopause, 19 for stress urinary incontinence, 3 for overactive bladder, 7 for urogenital prolapse, 3 for other indications). Data were heterogeneous, and level of evidence was weak or very weak. Few studies were comparative, and only 3 were randomized). Mild improvement of symptoms and quality of life and limited satisfaction were seen for genitourinary syndrome, stress urinary incontinence, overactive bladder and prolapse. Few adverse events were reported. However, major methodological biases were noted regarding efficacy and safety evaluation. No long-term results were available.While Vaginal LASER therapy seem to provide encouraging results, the level of evidence supporting its use was weak, especially regarding long-term outcomes. Studies of better quality are warranted before any recommendation can be made. Current use should be limited to clinical research.
- Published
- 2020
16. Complications after perineal surgery (with or without implantation of material): First results of the French multicenter observatory VIGIMESH after 1873 inclusions
- Author
-
X. Deffieux, C. Carlier-Guérin, Michel Cosson, J.-P. Lucot, S Curinier, A.C. Pizzoferrato, R. de Tayrac, P. Ferry, Delphine Salet-Lizee, Virginie Ringa, Stéphanie Ragot, Arnaud Fauconnier, Christian Saussine, Philippe Debodinance, Xavier Fritel, S. Campagne-Loiseau, Thomas Boisramé, Marie-Line Barussaud, and T. Charles
- Subjects
medicine.medical_specialty ,business.industry ,Observatory ,Urology ,medicine ,business ,lcsh:Diseases of the genitourinary system. Urology ,lcsh:RC870-923 ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,Surgery - Published
- 2020
17. Cure de cystocèle par prothèse vaginale libre de faible grammage : résultats à 6 ans
- Author
-
A. Zangarelli, A. Mansoor, S Campagne-Loiseau, S Curinier, L. Guy, CH Vichy, CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, CHU Gabriel Montpied [Clermont-Ferrand], Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Hôpital d'Issoire, and Partenaires INRAE
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Urology ,[SDV]Life Sciences [q-bio] ,030232 urology & nephrology ,Medicine ,business ,ComputingMilieux_MISCELLANEOUS ,3. Good health - Abstract
Resume Introduction L’objectif de cette etude etait d’evaluer a long terme, l’efficacite anatomique et fonctionnelle, mais aussi la prevalence des complications des protheses vaginales posees sans fixation dans la chirurgie de cystocele. Materiel et methodes Il s’agit d’une etude retrospective, monocentrique, incluant 90 patientes operees par voie vaginale d’un prolapsus uro-genital, entre juin 2006 et novembre 2008. Une prothese de polypropylene (Novasilk, COLOPLAST®) de faible grammage (22 g/m2) etait mise en place sans fixation en inter-vesico-vaginal. Les patientes etaient revues a 1 mois, 1 an, 3 ans et a plus de 6 ans. Seuls les resultats a long terme sont presentes dans cette etude. Le resultat anatomique etait apprecie par la classification de POP-Q et les resultats fonctionnels par des questionnaires standardises de symptomes (PFDI-20), de sexualite (PISQ-12) et de qualite de vie (PFIQ-7) Resultats A plus de 6 ans post-operatoire, la prevalence des perdues de vue etait de 26 % (n = 23). Sur le plan anatomique, la prevalence des recidives (Ba ≥ 0) etait de 17 % (n = 8). Sur le plan fonctionnel, la satisfaction globale des patientes etait de 89 %. Les scores de qualite de vie (4,11 ± 8,45 vs 17,5 ± 14,4, p Conclusion Dans cette courte serie retrospective d’interposition prothetique pour le traitement de la cystocele, la prevalence de satisfaction des patientes a moyen terme etait elevee.
- Published
- 2020
18. Laparoscopia y cirugía laparoscópica: principios generales e instrumental
- Author
-
P. Chauvet, B. Rabischong, S. Curinier, A.-S. Gremeau, N. Bourdel, A.-G. Kaemmerlen, C. Houlle, S. Campagne-Loiseau, J.-L. Pouly, M. Canis, and R. Botchorishvili
- Published
- 2018
19. Laparoscopia e chirurgia laparoscopica: principi generali e strumentazione
- Author
-
A G Kaemmerlen, S Campagne-Loiseau, Anne-Sophie Gremeau, C. Houlle, S Curinier, Nicolas Bourdel, B Rabischong, M. Canis, Pauline Chauvet, Revaz Botchorishvili, and J.-L. Pouly
- Subjects
03 medical and health sciences ,030219 obstetrics & reproductive medicine ,0302 clinical medicine ,030220 oncology & carcinogenesis - Abstract
La laparoscopia e una tecnica chirurgica moderna minimamente invasiva. Ha specificita e vincoli che e importante conoscere bene, per intraprenderla nelle migliori condizioni e per prevenire complicanze specifiche. Inoltre, la chirurgia laparoscopica dipende in gran parte dall’attrezzatura e dalla tecnologia che la accompagnano. Questo ambiente specifico richiede un apprendimento adeguato da parte del chirurgo.
- Published
- 2018
20. Les techniques de préservation nerveuse dans la chirurgie de l’endométriose profonde pour prévenir les séquelles fonctionnelles urinaires et digestives : modalités techniques et résultats. RPC Endométriose CNGOF-HAS
- Author
-
Benoit Rabischong, Nicolas Bourdel, Jean-Luc Pouly, S Curinier, S Campagne-Loiseau, Michel Canis, and Revaz Botchorishvili
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,030219 obstetrics & reproductive medicine ,0302 clinical medicine ,Nerve sparing ,Reproductive Medicine ,business.industry ,030220 oncology & carcinogenesis ,Obstetrics and Gynecology ,Medicine ,business - Abstract
Resume Objectifs Evaluer la faisabilite et les resultats fonctionnels urinaires et digestifs des techniques de preservation nerveuse dans la chirurgie de l’endometriose. Methodes Une recherche bibliographique sur la base de donnees medline/pubmed en utilisant des mots cles specifiques (nerve sparing, endometriosis, pelvic nerves) a permis d’identifier sept publications parmi une cinquantaine dont l’objet etaient de decrire la faisabilite, les techniques et les resultats fonctionnels de la preservation nerveuse dans cette indication. Parmi elles, on denombre : 2 etudes retrospectives non comparatives, 3 etudes prospectives non randomisees, une meta-analyse et une revue de la litterature. Resultats La preservation nerveuse necessite une parfaite connaissance de l’anatomie du systeme nerveux autonome pelvien. La voie coelioscopique est privilegiee par les differents auteurs. La faisabilite de cette technique semble demontree malgre certaines limites dans les differentes etudes et en fonction de l’extension retroperitoneale des lesions. Lorsqu’elle est faisable, elle est susceptible d’ameliorer significativement la fonction mictionnelle postoperatoire (retention urinaire) comparativement a une technique conventionnelle. Il n’est pas observe pas difference en ce qui concerne la fonction digestive. Conclusions La preservation nerveuse dans cette indication est une technique dont la faisabilite est demontree sous reserve de la topographie et de l’extension de la maladie. En l’absence d’envahissement ou d’engainement des nerfs autonomes pelviens par l’endometriose, cette technique ameliore la fonction mictionnelle postoperatoire (NP3). Au cours de la chirurgie pelvienne pour endometriose, il est recommande d’identifier et preserver les nerfs autonomes pelviens chaque fois que cela est possible (Grade C).
- Published
- 2018
21. Taux de complications et de récidives après chirurgie des prolapsus des organes pelviens : résultats à moyen terme d’une étude prospective chez 2341 patientes (Registre VIGI-MESH)
- Author
-
S. Campagne-Loiseau, C. Carlier, R. Ramanah, Michel Cosson, R. de Tayrac, Laurent Wagner, A.C. Pizzoferrato, Christian Saussine, P.O. Bosset, L. Panel, J.-P. Lucot, T. Charles, Thibault Thubert, Arnaud Fauconnier, L. Bressler, X. Deffieux, P. De Bodinance, Xavier Fritel, E. Nkounkou, P. Ferry, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, Hopital saint louis (LA ROCHELLE - Hôpital Saint Louis), CH La Rochelle, Service de réanimation chirurgicale [Béclère], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Groupe Hospitalier de l'Institut Catholique de Lille (GHICL), CHI Poissy-Saint-Germain, CH de Dunkerque, CHU Strasbourg, Service d'Urologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), CH de Châtellerault, Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Languedoc mutualité, Hôpital Foch [Suresnes], Centre hospitalier de Béthune, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Centre Hospitalier Universitaire de Nancy (CHU Nancy), and CHU Lille
- Subjects
Gynecology ,medicine.medical_specialty ,Prolapsus d'organe pelvien ,business.industry ,Urology ,030232 urology & nephrology ,[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery ,[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology ,Promontofixation ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,business - Abstract
International audience; Objectifs : le prolapsus des organes pelviens (POP) de la femme est une situation fréquente qui mène dans 19 % des cas à un traitement chirurgical. Le registre VIGI-MESH a permis de collecter les interventions chirurgicales de POP dans 19 centres et à surveiller les complications et les révisions chirurgicales. Nous présentons ici les premiers résultats à moyen terme de notre registre.Méthodes : l’analyse comprend 2 341 patientes dont la chirurgie prévue était une promontofixation par laparoscopie avec prothèse (n = 1 143), une chirurgie transvaginale avec prothèse (n = 694) ou sans prothèse (n = 504). La promontofixation a été converti dix fois (0,9 %) : 5 par laparotomie, 2 fixations latérales par laparoscopie, 3 voies transvaginale dont 2 avec prothèse. Les patientes étaient plus jeunes, avec moins de comorbidités dans le groupe promontofixation, et avec plus d’antécédents chirurgicaux chez les patients opérés par voie vaginale. Il y a une majorité de chirurgie avec prothèse en cas de prolapsus antérieur ou apical.Résultats : avec 15 mois de suivi médian, nous avons observé des complications Clavien–Dindo grade III ou plus chez 48 patientes (2,05 %). L’incidence de complications graves à 12 mois est significativement supérieure pour la réparation vaginale prothétique soit 3,71 % [2,28–5,13] versus 1,27 pour la réparation vaginale non prothétique [0,25–2,29] et 1,44 pour la promontofixation [0,71–2,167] avec p = 0,005 (Fig. 1). Il y a 29 réinterventions (1,24 %) en raison d’échec ou de récidive du prolapsus : 11 après promontofixation (0,96 %), 6 après prothèse vaginale (0,86 %) et 12 après réparation vaginale autologue (2,38 %). La réparation vaginale native comporte un risque de reprise chirurgicale pour prolapsus récidivé trois fois plus élevé qu’en cas de promontofixation (RR 0,34 [0,15–0,77]) ou de prothèse vaginale (RR = 0,29 [0,11–0,76]) .Conclusion : dans notre registre, la promontofixation présente le meilleur ratio bénéfice/risque par rapport à la réparation vaginale. Cette dernière expose à un faible risque de complications en cas de réparation autologue mais avec un risque de récidive 3 fois plus élevé et à l’inverse à un faible risque de récidive en cas de chirurgie prothétique mais avec un risque de complication grave 3 fois plus élevé.
- Published
- 2020
22. Réunions de concertation en pelvi-périnéologie en France : une enquête nationale auprès des urologues français
- Author
-
N. Berrogain, L. Donon, C. Thuillier, G. Meurette, J.-F. Hermieu, Laurent Wagner, Evelyne Ragni, L. Peyrat, P.O. Bosset, P. Roulette, A. Vidart, T. Charles, V. Cardot, J. Klap, S. Campagne-Loiseau, X. Deffieux, Jean-Nicolas Cornu, Brannwel Tibi, and F. Girard
- Subjects
business.industry ,Urology ,Medicine ,business ,Humanities - Abstract
Objectifs Les reunions de concertation pluridisciplinaires (RCP) en pelvi-perineologie prennent une importance grandissante dans la prise en charge des cas complexes en pelvi-perineologie et leur tenue pourrait devenir obligatoire pour poser certaines indications dans un futur proche. Le but de cette etude etait d’etablir un etat de lieux sur le territoire national concernant l’existence et les modalites de ces reunions. Methodes Une enquete a ete realisee aupres des urologues francais membres de l’Association francaise d’urologie via un questionnaire en ligne en 15 questions. Des statistiques descriptives ont ete menees. Resultats Les donnees demographiques relatives aux 207 urologues ayant repondu sont detaillees dans le Tableau 1 . Un acces a une RCP de pelvi-perineologie existait dans 37 % des cas. Les RCP impliquaient les CHU dans 57 % des cas. Le responsable etait urologue, gynecologue, digestif, MPR ou autre dans respectivement 38 %, 28 %, 8 %, 12 % et 14 % des cas. Outres les urologues, participaient des gynecologues (88 %), chirurgiens digestifs (74 %), gastro-enterologues (44 %), radiologues (37 %), MPR (40 %), kinesitherapeutes (43 %), algologues (12 %), infirmieres (19 %), geriatres (5 %) ou sage-femmes (9 %). Les activites etaient toujours des discussions de dossiers ( Tableau 2 ), parfois des presentations pedagogiques (34 %) et tres rarement des examens physiques des patients. Une liste d’emergement et un compte rendu ecrit existaient dans deux tiers des cas, mais un secretariat dedie dans seulement 29 % des cas. Conclusion Les RCP de pelvi-perineologie sont heterogenes et insuffisamment developpees en France, car beaucoup d’urologues declarent ne pas y avoir acces. Leur structuration, leur developpement et leur coordination sont des enjeux majeurs a court terme.
- Published
- 2020
23. Protocol for a randomized controlled trial to assess two procedures of vaginal native tissue repair for pelvic organ prolapse at the time of the questioning on vaginal prosthesis: the TAPP trial
- Author
-
E. Chantalat, Tristan Gauthier, A. Lacorre, Benoît Marin, Y. Aubard, F. Vidal, C. Mesnard, F. Siegerth, S. Campagne-Loiseau, and C. Hocke
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Medicine (miscellaneous) ,Prosthesis Design ,Prosthesis ,Pelvic Organ Prolapse ,law.invention ,03 medical and health sciences ,Study Protocol ,0302 clinical medicine ,Randomized controlled trial ,law ,Clinical endpoint ,medicine ,Humans ,Multicenter Studies as Topic ,Pharmacology (medical) ,030212 general & internal medicine ,Prospective Studies ,Prospective cohort study ,Randomized Controlled Trials as Topic ,Protocol (science) ,lcsh:R5-920 ,030219 obstetrics & reproductive medicine ,Pelvic floor ,business.industry ,Combined definition of success ,Pelvic fascia ,Pelvic Floor ,Plastic Surgery Procedures ,Surgery ,Anterior colporraphy ,Vaginal patch plastron ,medicine.anatomical_structure ,Treatment Outcome ,Hymen ,Patient Satisfaction ,Vagina ,Quality of Life ,Female ,France ,lcsh:Medicine (General) ,business ,Cystocele - Abstract
Background Native tissue cystocele repair has been the cornerstone of prolapse surgery, especially since the learned societies warned clinicians and patients about serious mesh-related complications. Surgical techniques mainly consist in anterior colporraphy and vaginal patch plastron. However, success rates of native tissue cystocele repair are heterogeneous, depending on the design of studies and definition of outcomes. To date, high-quality data comparing vaginal native tissue procedures are still lacking. Methods Herein we aimed to describe the design of the first randomized controlled trial (TAPP) comparing anterior colporraphy (plication of the muscularis and adventitial layers of the vaginal wall) and vaginal patch plastron (bladder support anchored on the tendinous arch of the pelvic fascia by lateral sutures) techniques. Our aim is to assess the effectiveness of vaginal native tissue repair at 1 year for cystocele with a combined definition of success—anatomic and functional. The primary endpoint will be the success rate 1 year after surgery with a composite of objective and subjective measures (Aa and Ba points Discussion A prospective study has found a success rate at 35% for anterior colporraphy based on a combined definition, both anatomic and functional, as recently recommended. However, the definition of anatomic was strict (POP-Q Trial registration CHU LIMOGES is the sponsor of this research (n°87RI18_0013). This research is supported by the French Department of Health (PHRC 2018-A03476-49) and will be conducted with the support of DGOS (PHRC interregional – GIRCI SOHO). The study protocol was approved by the Human Subjects Protection Review Board (Comité de Protection des Personnes) on May 16, 2019. The trial is registered in the ClinicalTrials.gov registry (NCT03875989).
- Published
- 2019
24. [Cystocele repair by a light tension-free vaginal mesh: results after 6 years of follow-up]
- Author
-
A, Zangarelli, S, Curinier, S, Campagne-Loiseau, L, Guy, and A, Mansoor
- Subjects
Adult ,Aged, 80 and over ,Time Factors ,Equipment Design ,Middle Aged ,Surgical Mesh ,Treatment Outcome ,Vagina ,Humans ,Female ,Cystocele ,Aged ,Follow-Up Studies ,Retrospective Studies - Abstract
The objective of this study was to evaluate the long-term anatomical and functional efficacy, but also the safety of tension-free vaginal mesh in cystocele repair.This retrospective and monocentric study included 90 women who underwent a prolapse repair between June 2006 and November 2008. A light-weight polypropylene vaginal mesh (22g/m2, Novasilk COLOPLAST®) was used without any fixation. Females were followed at 1 month, 1 year, 3 years and 6 years. Only long-term results are presented in this study. The anatomical result was assessed by the POP-Q classification and the functional results by standardized symptoms (PFDI-20), sexuality (PISQ-12) and quality of life (PFIQ-7) questionnaires.6 years after surgery, the follow-up rate was 74%. Anatomically, the prolapse recurrence rate (Ba≥0) was 17% (n=8). Functionally, the overall patient satisfaction rate was 89%. Quality of life and symptoms scores (4,11±8.45 vs. 17.5±14.4 and 35.8±15.9 vs 94±23.4 respectively) were significantly improved (p0.001). Concerning the prevalence of the complication, the retraction and exposition rate was 1.7% (n=1) and a re-intervention rate was 6.7% (n=4). The rate of de novo dyspareunia was 1.7% (n=1).In this short retrospective series of vaginal mesh interposition for cystocele repair, the prevalence of medium-term patient satisfaction was high.
- Published
- 2018
25. [Nerve sparing techniques in deep endometriosis surgery to prevent urinary or digestive functional disorders: Techniques and results: CNGOF-HAS Endometriosis Guidelines]
- Author
-
B, Rabischong, R, Botchorishvili, N, Bourdel, S, Curinier, S, Campagne-Loiseau, J L, Pouly, and M, Canis
- Subjects
Hypogastric Plexus ,Peripheral Nerve Injuries ,Endometriosis ,Humans ,Female ,Laparoscopy ,Urination Disorders ,Organ Sparing Treatments ,Pelvis - Abstract
To evaluate the feasibility and functional urinary and digestive results of nerve sparing techniques in endometriosis surgery.A research on the medline/pubmed database using specific keywords (nerve sparing, endometriosis, pelvic nerves) identified 7 publications among about 50 whose purpose was to describe the feasibility, the techniques and the functional results of nerve preservation in this indication. Among them there are: 2 uncontrolled retrospective studies, 3 prospective non-randomized studies, a meta-analysis and a review of the literature.Nerve preservation requires a perfect knowledge of the anatomy of the pelvic autonomic system. The laparoscopic approach is preferred by the different authors due to its anatomical advantage. The feasibility of this technique seems to be demonstrated despite certain limitations in the different studies and depending of the retroperitoneal extension of the lesions. When feasible, it is likely to significantly improve postoperative urinary function (urinary retention) compared to a conventional technique. It is observed no difference regarding digestive function.Nerve sparing in this indication is a technique the feasibility of which has been demonstrated and is subject to the topography and extent of the disease. In the absence of invasion or entrapment of pelvic autonomic nerves by endometriosis, this technique improves postoperative voiding function (NP3). During pelvic surgery for endometriosis, it is recommended to identify and preserve autonomic pelvic nerves whenever possible (GradeC).
- Published
- 2018
26. Safety of Vaginal Mesh Surgery Versus Laparoscopic Mesh Sacropexy for Cystocele Repair: Results of the Prosthetic Pelvic Floor Repair Randomized Controlled Trial
- Author
-
Michel Cosson, Denis Savary, Xavier Deffieux, Marion Ravit, Sébastien Blanc, Arnaud Fauconnier, Sandrine Fournet, Cherif Akladios, P. Ferry, S. Campagne-Loiseau, Georges Bader, Bernard Jacquetin, R. Villet, Arnaud Wattiez, Jean-Philippe Lucot, P Delporte, Renaud de Tayrac, Philippe Debodinance, Xavier Fritel, Delphine Salet-Lizee, CHRU de Lille, Hôpital Jeanne de Flandre, Service de gynécologie, 59000 Lille, France, Service de gynécologie obstétrique, CHI Poissy-Saint-Germain, CH de Dunkerke, Centre Hospitalier d'Arcachon, Physiologie et physiopathologie de la motricité chez l'homme, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR70-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Nîmes (CHRU Nîmes), Écologie et santé des écosystèmes (ESE), Institut National de la Recherche Agronomique (INRA)-AGROCAMPUS OUEST, CHU Estaing, Service de gynécologie-obstétrique [Hôpital Rothschild], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Rothschild-Sorbonne Université (SU), Service de gynécologie et obstétrique [CHI Poissy-Saint Germain], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Service de Gynécologie [CHU Clermont-Ferrand], CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Hôpital Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Risques cliniques et sécurité en santé des femmes et en santé périnatale (RISCQ), and Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
- Subjects
medicine.medical_specialty ,Time Factors ,Urology ,030232 urology & nephrology ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,law.invention ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Randomized controlled trial ,Risk Factors ,law ,Statistical significance ,medicine ,Humans ,Stage (cooking) ,Laparoscopy ,ComputingMilieux_MISCELLANEOUS ,Aged ,030219 obstetrics & reproductive medicine ,Pelvic floor ,medicine.diagnostic_test ,business.industry ,Suture Techniques ,Pelvic Floor ,Recovery of Function ,Middle Aged ,Surgical Mesh ,Confidence interval ,3. Good health ,Surgery ,Treatment Outcome ,Surgical mesh ,medicine.anatomical_structure ,Quality of Life ,Urologic Surgical Procedures ,Female ,France ,business ,Sexual function ,Cystocele - Abstract
Background Laparoscopic mesh sacropexy (LS) or transvaginal mesh repair (TVM) are surgical techniques used to treat cystoceles. Health authorities have highlighted the need for comparative studies to evaluate the safety of surgeries with meshes. Objective To compare the rate of complications, and functional and anatomical outcomes between LS and TVM. Design, setting, and participants Multicenter randomized controlled trial from October 2012 to April 2014 in 11 French public hospitals. Women with cystocele stage ≥2 (pelvic organ prolapse quantification), aged 45–75 yr, without previous prolapse surgery. Intervention Synthetic nonabsorbable mesh placed in the vesicovaginal space, sutured to the promontory (LS) or maintained by arms through pelvic ligaments (TVM). Outcome measurements and statistical analysis Rate of surgical complications ≥grade II according to the modified Clavien–Dindo classification at 1 yr. Secondary outcomes were reintervention rate, and functional and anatomical results. Results and limitations A total of 130 women were randomized in LS and 132 in TVM; five women withdrew before intervention, leaving 129 in LS and 128 in TVM. The rate of complications ≥grade II was lower after LS than after TVM, but did not meet statistical significance (17% vs 26%, treatment difference 8.6% [95% confidence interval, CI −1.5 to 18]; p =0.088). The rate of complications of grade III or higher was nonetheless significantly lower after LS (LS=0.8%, TVM=9.4%, treatment difference 8.6% [95% CI 3.4%; 15%]; p =0.001). LS was converted to TVM in 6.3%. The total reoperation rate was lower after LS but did not meet statistical significance (LS=4.7%, TVM=10.9%, treatment difference 6.3% [95% CI −0.4 to 13.3]; p =0.060). There was no difference in symptoms, quality of life, improvement, composite definition of success, anatomical results rates between groups except for the vaginal apex and length, and dyspareunia (in favor of LS). Conclusions LS is a valuable option for primary repair of cystocele in sexually active patients. LS is safer than TVM, but may not be feasible in all cases. Both techniques offer same functional outcomes, success rates, and anatomical outcomes, but sexual function is better preserved by LS. Patient summary Our study demonstrates that laparoscopic sacropexy (LS) is a valuable option for primary repair of cystocele. LS offers equivalent success rates to vaginal mesh procedures, but is safer with a lower rate of complications and reoperations, and sexual function is better preserved.
- Published
- 2018
27. Complications après chirurgie du périnée (avec ou sans implantation de matériel) : premiers résultats de l’observatoire multicentrique français VIGIMESH après 1873 inclusions
- Author
-
Delphine Salet-Lizee, Michel Hummel, X. Deffieux, T. Charles, A.C. Pizzoferrato, Thomas Boisramé, Xavier Fritel, S. Campagne Loiseau, Virginie Ringa, P. Ferry, Christian Saussine, Arnaud Fauconnier, C. Carlier-Guérin, R. de Tayrac, Michel Cosson, J.-P. Lucot, Stéphanie Ragot, Marie-Line Barussaud, and Jean-Philippe Debodinance
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Urology ,medicine ,business - Abstract
Objectifs Lors d’une chirurgie pour incontinence urinaire d’effort et/ou prolapsus genital des dispositifs medicaux non-resorbables sont souvent utilises. Les complications dependent de l’experience du chirurgien, des caracteristiques des patientes, de la voie d’abord, de la technique de pose, et des materiaux utilises. L’observatoire VIGIMESH permet depuis 2017 un recueil prospectif de l’utilisation de ces dispositifs et de leurs complications (exposition, complications fonctionnelles [douleur, obstruction, consequences sexuelles]). Methodes A partir de fevrier 2017, dans les 13 centres participants toutes les patientes operees d’une incontinence urinaire d’effort (IUE) et/ou un prolapsus genital ou rectal pouvaient participer au suivi. Seuls les patientes ayant une bandelette sous-uretrale (BSU) ou une colposuspension, une reparation vaginale avec ou sans meche par voie vaginale ou abdominale ou une reparation endo-anale ont ete incluses. Les patientes ayant une pose de sphincter urinaire artificiel, de ballons peri-uretraux ou des injections de produits de comblements n’ont pas ete incluses. Chaque chirurgien declarait leurs interventions et complications. Celles-ci etaient verifiees avec les informations du departement d’information medicale et par des questionnaires de suivi. Resultats Au total, 1873 patientes ont ete incluses et analysees. Les chirurgies index ont ete reparties en 5 groupes ( Tableau 1 ). Les patientes operees d’une IUE isolee par BSU ont beneficie dans la moitie des cas d’une procedure retropubienne (338 cas soit 51,4 %). Quinze patientes ont eu un colpocleisis dans le groupe reparation vaginale sans materiel. Soixante-trois plaies peroperatoires (3,36 %) ont ete rapportes (34 de vessie, 2 de l’uretre, 2 du rectum et 19 du vagin). Seulement dans 8 cas ces plaies ont amene a l’arret de l’intervention et/ou de la mise en place de materiel. Cinquante-deux patientes (2,78 %) ont eu des complications graves durant la chirurgie ou dans les premiers mois postoperatoires (grade III ou plus) ( Tableau 2 et Fig. 1 ). Sept patientes ont necessite de multiples interventions pour traiter la complication. Conclusion L’observatoire est un outil qui permet de rapporter, de facon organisee, les complications des chirurgies du plancher pelvien et permettra sur le plus long terme de comparer les differents materiaux utilises et techniques d’implantation. Il permettra egalement a terme de proposer des recommandations sur la prevention et la prise en charge des complications de ces chirurgies et de leurs sequelles.
- Published
- 2019
28. [Information to patients in endometriosis: We must stop the frightening machine!]
- Author
-
M, Canis, S, Curinier, S, Campagne-Loiseau, A G, Kaemerlen Rabischong, B, Rabischong, J L, Pouly, A S, Grémeau, R, Botchorishvili, and N, Bourdel
- Subjects
Patient Education as Topic ,Endometriosis ,Humans ,Female ,Fear ,Infertility, Female - Published
- 2016
29. Teaching Surgery for Endometriosis Using Patient Language!
- Author
-
J.-L. Pouly, Revaz Botchorishvili, Anne-Sophie Gremeau, Benoit Rabischong, Nicolas Bourdel, Pauline Chauvet, Sandra Curinier, M. Canis, and S. Campagne Loiseau
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,Endometriosis ,Obstetrics and Gynecology ,business ,medicine.disease ,Surgery - Published
- 2018
30. [Not Available]
- Author
-
A, Zangarelli, S, Curinier, S, Campagne-Loiseau, B, Rabischong, A, Mansoor, and L, Guy
- Published
- 2015
31. [Not Available]
- Author
-
V, Delmas, B, Jacquetin, R, Villet, S, Campagne-Loiseau, and D, Salet-Lizée
- Published
- 2015
32. Erratum à l’article « Étude randomisée comparant la promontofixation cœlioscopique à la chirurgie prothétique par voie vaginale pour le traitement des cystocèles : PROSPERE (PROSthetic PElvic organ prolapse REpair) » [J. Gynecol. Obstet. Biol. Reprod. 42(4) (2013) 334–341]
- Author
-
S. Campagne-Loiseau, R. de Tayrac, J.-P. Lucot, M. Lesavre, Georges Bader, O. Garbin, C. Rubod, S Blanc, C Youssef Azer Akladios, Philippe Debodinance, X. Deffieux, Y Thirouard, Xavier Fritel, J.-F. Hermieu, Christian Saussine, P. Ferry, J S Aucouturier, Vincent Delmas, Michel Cosson, P. Collinet, S Fournet, Laurent Wagner, Géraldine Giraudet, E. Faivre, R Botchorichvili, Didier Tardif, Brigitte Fatton, Delphine Salet-Lizee, Arnaud Wattiez, Bernard Jacquetin, R. Villet, E Baulon-Thaveau, Cédric Nadeau, Hervé Fernandez, C. Trichot, G. Demoulin, Arnaud Fauconnier, Pierre Gadonneix, V. Thoma, Denis Savary, and P Delporte
- Subjects
Reproductive Medicine ,Obstetrics and Gynecology ,General Medicine - Abstract
Journal de Gynecologie Obstetrique et Biologie de la Reproduction - Vol. 42 - N° 5 - p. 499-501
- Published
- 2013
33. Endométriose : information aux patientes – il faut arrêter la machine à faire peur !
- Author
-
Michel Canis, Benoit Rabischong, S Campagne-Loiseau, J.-L. Pouly, Revaz Botchorishvili, A.G. Kaemerlen Rabischong, Nicolas Bourdel, Anne-Sophie Gremeau, and S Curinier
- Subjects
03 medical and health sciences ,030219 obstetrics & reproductive medicine ,0302 clinical medicine ,Reproductive Medicine ,business.industry ,Obstetrics and Gynecology ,Medicine ,General Medicine ,business ,030217 neurology & neurosurgery - Published
- 2016
34. Étude randomisée comparant la promontofixation cœlioscopique à la chirurgie prothétique par voie vaginale pour le traitement des cystocèles : PROSPERE (PROSthetic PElvic organ prolapse REpair)
- Author
-
C. Rubod, E Baulon Thaveau, S Fournet, D. Tardif, A. Fauconnier, E. Faivre, C Youssef Azer Akladios, Y Thirouard, X. Deffieux, P Delporte, P. Ferry, J S Aucouturier, S. Campagne Loiseau, Laurent Wagner, P. Collinet, Delphine Salet-Lizee, Denis Savary, Hervé Fernandez, Georges Bader, R Botchorichvili, Cédric Nadeau, R. Villet, Brigitte Fatton, Arnaud Wattiez, Bernard Jacquetin, J.-P. Lucot, G. Demoulin, C. Trichot, Géraldine Giraudet, Michel Cosson, M. Lesavre, Pierre Gadonneix, V. Thoma, S Blanc, J.-F. Hermieu, Christian Saussine, R. de Tayrac, O. Garbin, Philippe Debodinance, Xavier Fritel, Vincent Delmas, Service de gynécologie et obstétrique [Poitiers], Centre hospitalier universitaire de Poitiers (CHU Poitiers), Laboratoire de Mécanique de Lille - FRE 3723 (LML), Université de Lille, Sciences et Technologies-Centrale Lille-Centre National de la Recherche Scientifique (CNRS), Hôpital Jeanne de Flandres, Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHRU de Lille, Hôpital Jeanne de Flandre, Service de gynécologie, 59000 Lille, France, Physiologie et physiopathologie de la motricité chez l'homme, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR70-Institut National de la Santé et de la Recherche Médicale (INSERM), Departement des Sciences de la Terre, Ecole Nationale Superieure de Lyon, Service de gynécologie obsétrique, Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Université Paris Descartes - Paris 5 (UPD5), Département Ecologie, Physiologie et Ethologie (DEPE-IPHC), Institut Pluridisciplinaire Hubert Curien (IPHC), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS)-Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Risques cliniques et sécurité en santé des femmes et en santé périnatale (RISCQ), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Centre National de la Recherche Scientifique (CNRS)-Université de Lille, Sciences et Technologies-Ecole Centrale de Lille-Université de Lille, Hôpital Universitaire Carémeau [Nîmes], Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Service de Gynécologie Obstétrique, Hôpital de Poissy Saint Germain en Laye, 10 rue du Champ Gaillard, Poissy, France., CHI Poissy-Saint-Germain, Service de Gynécologie - Obstétrique [Lille], and Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
- Subjects
Gynecology ,medicine.medical_specialty ,030219 obstetrics & reproductive medicine ,business.industry ,Obstetrics and Gynecology ,General Medicine ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Reproductive Medicine ,Multicenter study ,030220 oncology & carcinogenesis ,medicine ,Prolapsus genital ,business ,ComputingMilieux_MISCELLANEOUS - Abstract
Resume Contexte La cystocele constitue la forme clinique la plus frequente du prolapsus genital de la femme. Il s’agit d’une pathologie frequente et invalidante. Le traitement chirurgical de reference en est la promontofixation indirecte par prothese synthetique sous-vesicale par laparotomie. L’abord cœlioscopique tend a supplanter la laparotomie. L’utilisation de la voie d’abord vaginale pour la mise en place d’une prothese sous-vesicale pourrait presenter de nombreux interets : simplicite de realisation, duree operatoire moindre, convalescence plus courte, mais pourrait exposer a une morbidite accrue en ce qui concerne les complications liees aux protheses. La promontofixation indirecte cœlioscopique et la mise en place de protheses par voie vaginale sont couramment pratiquees en France bien que la HAS ait souligne l’absence d’evaluation suffisante de la securite et de la tolerance de la mise en place des protheses synthetiques par voie vaginale. Methode L’objectif principal de l’etude est de comparer la morbidite de la promontofixation cœlioscopique a la chirurgie par voie vaginale pour le traitement des cystoceles par prothese synthetique sous-vesicale. Le critere principal d’evaluation sera le taux de complications chirurgicales superieur ou egal au grade II de la classification de Clavien-Dindo survenant dans l’annee de suivi. Les objectifs secondaires sont de comparer les resultats fonctionnels a moyen terme (sexualite, signes fonctionnels urinaires et digestifs, douleurs), le retentissement sur la qualite de vie, ainsi que les resultats anatomiques. PROSPERE est une etude prospective randomisee multicentrique qui sera menee dans 12 centres hospitaliers francais. Deux cent soixante-deux patientes ayant une cystocele superieure ou egale au stade 2 POP-Q isolee ou non, âgees de 45 a 75 ans, seront inclues. Les patientes ne doivent pas avoir d’antecedent de chirurgie du prolapsus ou de conditions defavorables ou contre-indiquant l’une ou l’autre des voies d’abord. La realisation de cette etude devrait permettre de repondre a la problematique non resolue actuellement du choix de la voie d’abord pour la pose des renforts prothetiques sous-vesicaux. Cet essai permettrait de mieux determiner les indications respectives de l’une ou l’autre de ces voies d’abord, qui reposent actuellement sur des attitudes d’ecoles et des choix subjectifs.
- Published
- 2013
35. [PROSPERE randomized controlled trial: laparoscopic sacropexy versus vaginal mesh for cystocele POP repair]
- Author
-
J-P, Lucot, X, Fritel, P, Debodinance, G, Bader, M, Cosson, G, Giraudet, P, Collinet, C, Rubod, H, Fernandez, S, Fournet, M, Lesavre, X, Deffieux, E, Faivre, C, Trichot, G, Demoulin, B, Jacquetin, D, Savary, R, Botchorichvili, S, Campagne Loiseau, D, Salet-Lizee, R, Villet, P, Gadonneix, P, Delporte, P, Ferry, J S, Aucouturier, Y, Thirouard, R, de Tayrac, B, Fatton, L, Wagner, C, Nadeau, A, Wattiez, O, Garbin, C, Youssef Azer Akladios, V, Thoma, E, Baulon Thaveau, C, Saussine, J F, Hermieu, V, Delmas, S, Blanc, D, Tardif, and A, Fauconnier
- Subjects
Prostheses and Implants ,Middle Aged ,Plastic Surgery Procedures ,Surgical Mesh ,Hysterectomy ,Gynecologic Surgical Procedures ,Urinary Incontinence ,Uterine Prolapse ,Vagina ,Humans ,Female ,Laparoscopy ,Cystocele ,Aged - Abstract
Cystocele is a frequent and invalidating type of genital prolapse in woman. Sacropexy using synthetic mesh is considered the surgical gold standard, and the laparoscopic approach has supplanted the open abdominal route because it offers the same anatomical results with a lower morbidity. The use of mesh through the vaginal route may have many advantages: easiness to perform, shorter operative time and recovery, but may increase morbidity. In France, both laparoscopic sacropexy and vaginal mesh are commonly used to treat cystoceles. The French Haute Autorité de santé (HAS) has highlighted the lack of evaluation of safety assessment for vaginal meshes.The main objective of the study is to compare the morbidity of laparoscopic sacropexy with vaginal mesh for cystocele repair. The primary endpoint will be the rate of surgical complications greater or equal to grade 2 of the Clavien-Dindo classification at 1-year follow-up. The secondary aims are to compare the functional results in the medium term (sexuality, urinary and bowel symptoms, pain), the impact on quality of life as well as anatomical results. PROSPERE is a randomized controlled trial conducted in 12 participating French hospitals. 262 patients, aged 45 to 75years old, with cystocele greater or equal to stage 2 of the POP-Q classification (isolated or not) will be included. Exclusion criterias are a previous surgical POP repair, and inability or contra-indication to one or the other technique. We have designed this study to answer the question of the choice between laparoscopic sacropexy and vaginal mesh for the treatment of cystocele. The PROSPERE trial aims to help better determine the indications for one or the other of these techniques, which are currently based on subjective choices or school attitudes. This is the reason why competent authorities have asked for such studies.
- Published
- 2013
36. Cure de cystocèle par prothèse libre intervésico-vaginale : résultats anatomiques et fonctionnels à plus de 6ans chez une cohorte de 90 patientes
- Author
-
Benoit Rabischong, S Campagne-Loiseau, S Curinier, A. Mansoor, A. Zangarelli, and L. Guy
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Urology ,medicine ,business - Abstract
Objectifs Le traitement de la cystocele par voie vaginale est un challenge. De nombreux implants prothetiques ainsi que de nombreuses techniques de pose ont ete developpees afin d’effectuer une reparation optimale du prolapsus genital. L’objectif de cette etude est d’etudier le benefice anatomique et fonctionnel a long terme de la mise en place d’une prothese libre de polypropylene posee en intervesico-vaginale dans la cure de cystocele. Methodes Quatre-vingt dix patientes operees entre juin 2006 et novembre 2008 ont ete incluses dans une cohorte. Les patientes sont revues a 1, 6, 12 mois, 4 ans et a plus de 6 ans postoperatoire. Des questionnaires de symptomes, de sexualite et de qualite de vie ont ete utilises avant et apres l’intervention pour evaluer les resultats fonctionnels. La classification POP-Q a ete utilisee pour l’evaluation anatomique du prolapsus. Une attention particuliere a ete donnee a la tolerance de la prothese (exposition, retraction, infection, douleur). Une prothese de polypropylene de faible grammage, 22 g/m 2 , Novasilk (Coloplast) a ete confectionnee et est utilisee dans cette etude sans aucune tension. Resultats Le taux de suivi a 79 mois est de 74,4 % (63 patientes). Quatre patientes sont decedees. L’âge moyen au moment de l’intervention etait de 67,6 ans. Les resultats fonctionnels a 6 ans et demi sont tres satisfaisants avec des taux de satisfaction de 89 %. Les scores de qualite de vie et de symptomes ont ete significativement ameliores. Sur le plan anatomique, le taux de recidive (Ba ≥ 0) est de 16,7 %. Les taux de complications peri et post-operatoires observes dans cette technique de prothese posee sans tension, sont faibles. Le taux de retraction et d’exposition de la prothese est de l’ordre de 1,7 %. Le taux de re-intervention est de 6,7 %. Aucune patiente n’a ete re-operee pour recidive de cystocele. Le taux de dyspareunie de novo est de 1,7 %. Conclusion Cette technique de Prothese InterVesico-Vaginale (PIVV) libre dans la cure des cystoceles, donne des resultats anatomiques et fonctionnels satisfaisants et stables a tres long terme, avec un taux de complications et re-interventions tres faible, rendant cette technique acceptable pour une chirurgie fonctionnelle.
- Published
- 2014
37. Amarrage sur le ligament sacro-épineux, fixation antérieure ou postérieure ?
- Author
-
Delphine Salet-Lizee, S. Campagne-Loiseau, R. Villet, Bernard Jacquetin, and Vincent Delmas
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Urology ,Medicine ,business - Abstract
Objectifs Le soutien du col uterin se fait dans le parametre, celui de la vessie se fait le long de l’ATFP. Dans tous les cas, un point d’appui est a rechercher en arriere. Par voie vaginale, le ligament sacro-epineux est ce point d’ancrage realisable par voie transgluteale ou pelvienne Le but de cette etude est de comparer les risques anatomiques de ces deux voies. Methodes L’etude a porte sur 5 sujets feminins, (don du corps a la science), non formoles. Dans un premier temps etait effectue le geste operatoire comme pour fixer le bras posterieur d’une prothese pour cure de prolapsus par voie vaginale : colpotomie anterieure, dissection intervesico-vaginale, reperage de l’epine ischiatique et du ligament sacro-epineux, passage d’un ancillaire : par voie anterieure ou posterieure ; positionnement des fils de soutien comme pour la correction d’une cystocele ou d’un prolapsus du dome par voie vaginale. Une dissection etait menee par voie fessiere et abdominale pour verifier le lieu de passage et les structures concernees par le passage des fils. Resultats 1. Passage transgluteal : bord inferieur du muscle grand gluteal, dans la fosse ischio-anale, les vaisseaux rectaux inferieurs ; reperage de l’epine ischiatique et du ligament sacro-epineux, la prothese passait 1 cm en dedans dans le ligament sacro-epineux : artere et nerf pudendal etaient situes plus en dehors, derriere ou a proximite de l’epine et l’artere gluteale inferieure au dessus. 2. Abord anterieur paravesical : face superieure du muscle levatorani ; traversee de la partie inferieure du ligament cardinal avec le pedicule uterin situe transversalement et, a sa partie mediale, l’uretere (croisement de l’artere uterine avec l’uretere) et le plexus hypogastrique inferieur au dessus du cul-de-sac lateral du vagin ; le ligament sacro-epineux sur sa face anterieure etait recouvert du fascia pelvien et du muscle coccygien. Conclusion La voie anterieure passe dans les parametres (pedicules uterovaginaux et uretere), dans les tissus preligamentaires qu’il faut ecarter ; la voie posterieure passe dans la fesse mais donne une prise plus sure. L’ideal pourrait etre une voie minimale combinee assurant la securite de la prise ligamentaire par voie posterieure et le trajet mini-invasif par voie anterieure.
- Published
- 2014
38. Complications, revision and perceived health after surgery for stress urinary incontinence by mid urethra sling inthe VIGI-MESH register: Description and medium-term incidence for 1814 women
- Author
-
Michel Hummel, Arnaud Fauconnier, C. Carlier-Guérin, E. Nkounkou, A-C Pizzoferrato, A. Vidart, P. Ferry, Xavier Deffieux, R. Ramanah, Michel Cosson, T. Thubert, Christian Saussine, J.-P. Lucot, T. Charles, L. Panel, S. Campagne-Loiseau, Philippe Debodinance, Xavier Fritel, and Laurent Wagner
- Subjects
medicine.medical_specialty ,Sling (implant) ,business.industry ,Urology ,Incidence (epidemiology) ,Urinary incontinence ,Medium term ,Surgery ,Perceived health ,Urethra ,medicine.anatomical_structure ,Register (music) ,medicine ,medicine.symptom ,business
39. Perceived health status after mid-urethral sling revision in 287 women from the VIGI-MESH registry: A cross-sectional study.
- Author
-
Camilli H, Fatton B, Gand E, Campagne-Loiseau S, De Tayrac R, Wagner L, Saussine C, Rigaud J, Thubert T, Deffieux X, Cosson M, Ferry P, Capon G, Panel L, Chartier-Kastler E, Gauthier T, Game X, Bouynat C, Bichon R, Fauconnier A, Pizzoferrato AC, and Fritel X
- Subjects
- Humans, Female, Cross-Sectional Studies, Middle Aged, Surveys and Questionnaires, France, Urinary Incontinence, Stress surgery, Aged, Adult, Postoperative Complications epidemiology, Postoperative Complications etiology, Quality of Life, Suburethral Slings, Health Status, Registries, Reoperation statistics & numerical data
- Abstract
Objective: To evaluate the health status and recovery of women after mid-urethral sling (MUS) revision in response to complications., Design: Cross-sectional study using a questionnaire sent to women from a registry., Setting: Twenty-two French surgical centres., Population: A total of 287 women from the VIGI-MESH registry responded, having undergone MUS revision for complications., Methods: Our sample of women were compared against a representative set of French women taken from the Eurostat database. Multivariate analysis was performed to identify clinical predictors for successful MUS revision. A qualitative analysis was carried out on free-text comments., Main Outcome Measures: Health status, defined by the Minimum European Health Module, and recovery, assessed by Patient Global Impression of Improvement., Results: The response rate was 76% (287/378), with 49% of the women (141/287, 95% CI 43%-55%) reporting good health status, which was 8 points lower than that expected from the comparator French set (57%, 95% CI 55%-58%). Overall, 53% (147/275, 95% CI 47%-59%) of the women reported feeling much better after MUS revision. Just over one-third (35%, 95/275, 95% CI 29%-40%) of respondents reported poor health with little or no improvement. Multivariate analysis showed that being operated on for pain at revision was associated with worse self-perceived health than being operated on for exposure (OR 0.36, 95% CI 0.14-0.95); women with pre-existing comorbidity reported a poorer health status following MUS revision (OR 0.22, 95% CI 0.13-0.38)., Conclusions: Our results suggest that half of the women recovered good health status after MUS revision, whereas a proportion appeared to be seriously affected by an MUS complication despite the revision., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
40. Management of Complications of Prosthetic Mid-urethral Tape Surgery for Stress Urinary Incontinence in Women.
- Author
-
Stivalet-Schoentgen N, Perrouin Verbe MA, Campagne-Loiseau S, Donon L, Levesque A, Rigaud J, Venara A, Thubert T, Vidart A, Bosset PO, Revel-Delhom C, Lucot JP, Deffieux X, and Hermieu JF
- Abstract
Objective: To propose guidelines for the management of complications of prosthetic mid-urethral tape surgery for stress urinary incontinence in women., Methods: These guidelines are based on an exhaustive literature review on retropubic and trans-obturator mid-urethral tape complications. The expert panel rated the level of evidence of each study, summarized literature for the treatment of each complication, and proposed guidelines., Results: Management of these complications is complex and the first treatment is crucial to offer the best functional result to the patient. We propose a standardized approach and guidelines for the management of complications to help physicians to early identify a surgical complication, offer adequate treatment for each complication and provide clear and appropriate information to patients. We detailed management of intraoperative complications as follows: bladder, urethral, vaginal, visceral, and vascular injury; short-term post-operative complications are the following: bleeding/hematoma, voiding dysfunction, pain, infection; and long-term post-operative complications are the following: chronic voiding dysfunction, de novo overactive bladder syndrome, chronic pain, dyspareunia, vaginal, bladder, and urethral tape erosion., Conclusion: These guidelines may help physicians to improve management of prosthetic mid-urethral sling complications that may occur following stress urinary incontinence surgery., Competing Interests: Declaration of Competing Interest The authors declare that they have no conflict of interest., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
41. New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study.
- Author
-
Cornu JN, Donon L, Thullier C, Meyer F, Klap J, Campagne-Loiseau S, Mariadassou A, and Peyronnet B
- Abstract
Background and Objective: Our aim was to report the first clinical trial of TENSI+, a new device for transcutaneous posterior tibial nerve stimulation (TNS) for treatment of overactive bladder (OAB)., Methods: A prospective, multicentre clinical trial was conducted in adults with OAB in seven French centres. The main exclusion criteria were prior percutaneous or transcutaneous TNS or invasive OAB treatment, current antimuscarinic use, 24-h polyuria, known bladder disease, postvoid residual volume >150 ml, and pelvic organ prolapse stage >2. Patients self-administered daily TTNS sessions of 20 min with TENSI+ at home after education by a specialized nurse. A bladder diary, Urinary Symptom Profile and OAB-q questionnaires, and Patient Global Impression of Improvement (PGI-I) scores were evaluated at baseline and 3 and 6 mo. The primary endpoint was efficacy, based on PGI-I and variations in bladder diary parameters. Success was defined as a PGI-I score ≤3 and any improvement ≥30% in bladder diary parameters., Key Findings and Limitations: The study included 78 patients (13 males). Nine patients had neurological disease, 21 had previously tried antimuscarinics, and 41 had wet OAB at baseline. At 3 mo, 65/78 patients had a full analysis set. Treatment was successful in 44/65 patients (67%), with 25/65 (38%) reporting both an objective improvement and high satisfaction. All OAB-related endpoints were significantly improved, except bladder capacity and total voided volume per 24 h. At 6 mo, only five of 44 patients had interrupted their treatment. No factor predictive of success was identified. Two adverse events (pain at stimulation site and/or pelvic pain) were reported and spontaneously resolved without treatment interruption., Conclusions and Clinical Implications: TENSI+ is a safe and effective TTNS treatment option for OAB management., Patient Summary: TENSI+ is a new device for nerve stimulation in patients with overactive bladder. Patients use the device at home every day. In our short-term trial, TENSI+ use improved symptoms in 67% of patients. Further evaluation over a longer period of time is needed., (Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. Serious complications and recurrences after retropubic vs transobturator midurethral sling procedures for 2682 patients in the VIGI-MESH register.
- Author
-
Armengaud C, Fauconnier A, Drioueche H, Campagne Loiseau S, De Tayrac R, Saussine C, Panel L, Cosson M, Deffieux X, Lucot JP, Pizzoferrato AC, Ferry P, Vidart A, Thubert T, Capon G, Debodinance P, Gauthier T, Koebele A, Salet-Lizee D, Hermieu JF, Game X, Ramanah R, Lamblin G, Lecornet E, Carlier-Guérin C, Chartier-Kastler E, and Fritel X
- Subjects
- Female, Humans, Surgical Mesh, Urologic Surgical Procedures methods, Reoperation, Urinary Incontinence, Stress surgery, Urinary Incontinence, Stress etiology, Suburethral Slings adverse effects
- Abstract
Background: Midurethral slings are the gold standard for treating stress urinary incontinence, but their complications may raise concerns. Complications may differ by the approach used to place them., Objective: This study aimed to compare serious complications and reoperations for recurrence after midurethral sling procedures when using the retropubic vs the transobturator route for female stress urinary incontinence., Study Design: This analysis was of patients included in the French, multicenter VIGI-MESH register since February 2017 who received a midurethral sling for female stress urinary incontinence either by the retropubic or the transobturator route and excluded patients with single-incision slings. Follow-up continued until October 2021. Serious complications (Clavien-Dindo classification ≥ grade III) attributable to the midurethral sling and reoperations for recurrence were compared using Cox proportional hazard models including any associated surgery (hysterectomy or prolapse) and a frailty term to consider the center effect. Baseline differences were balanced by propensity score weighting. Analyses using the propensity score and Cox models were adjusted for baseline differences, center effect, and associated surgery., Results: A total of 1830 participants received a retropubic sling and 852 received a transobturator sling in 27 French centers that were placed by 167 surgeons. The cumulative 2-year estimate of serious complications was 5.8% (95% confidence interval, 4.8-7.0) in the retropubic group and 2.9% (95% confidence interval, 1.9-4.3) in the transobturator group, that is, after adjustment, half of the retropubic group was affected (adjusted hazard ratio, 0.41; 95% confidence interval, 0.3-0.6). The cumulative 2-year estimate of reoperation for recurrence of stress urinary incontinence was 2.7% (95% confidence interval, 2.0-3.6) in the retropubic group and 2.8% (95% confidence interval, 1.7-4.2) in the transobturator group with risk for revision for recurrence being higher in the transobturator group after adjustment (adjusted hazard ratio, 1.9; 95% confidence interval, 1.2-2.9); this surplus risk disappeared after exclusion of the patients with a previous surgery for stress urinary incontinence., Conclusion: The transobturator route for midurethral sling placement is associated with a lower risk for serious complications but a higher risk for surgical reoperation for recurrence than the retropubic route. Despite the large number of surgeons involved, these risks were low. The data are therefore reassuring., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
43. Diagnosis and management of complications following pelvic organ prolapse surgery using a synthetic mesh: French national guidelines for clinical practice.
- Author
-
Deffieux X, Perrouin-Verbe MA, Campagne-Loiseau S, Donon L, Levesque A, Rigaud J, Stivalet N, Venara A, Thubert T, Vidart A, Bosset PO, Revel-Delhom C, Lucot JP, and Hermieu JF
- Subjects
- Humans, Female, Surgical Mesh adverse effects, Polypropylenes, Quality of Life, Abscess etiology, Hyperalgesia etiology, Vagina, Prostheses and Implants, Pain, Postoperative etiology, Anti-Bacterial Agents, Estrogens, Pelvic Pain etiology, Polyesters, Treatment Outcome, Discitis etiology, Dyspareunia etiology, Pelvic Organ Prolapse surgery, Pelvic Organ Prolapse etiology, Urinary Bladder Diseases etiology, Myofascial Pain Syndromes etiology, Neuralgia etiology
- Abstract
Complications associated with pelvic organ prolapse (POP) surgery using a synthetic non-absorbable mesh are uncommon (<5%) but may be severe and may hugely diminish the quality of life of some women. In drawing up these multidisciplinary clinical practice recommendations, the French National Authority for Health (Haute Autorité de santé, HAS) conducted an exhaustive review of the literature concerning the diagnosis, prevention, and management of complications associated with POP surgery using a synthetic mesh. Each recommendation for practice was allocated a grade (A,B or C; or expert opinion (EO)), which depends on the level of evidence (clinical practice guidelines)., Preoperative Patients' Information: Each patient must be informed concerning the risks associated with POP surgery (EO)., Hemorrhage, Hematoma: Vaginal infiltration using a vasoconstrictive solution is not recommended during POP surgery by the vaginal route (grade C). The placement of vaginal packing is not recommended following POP surgery by the vaginal route (grade C). During laparoscopic sacral colpopexy, when the promontory seems highly dangerous or when severe adhesions prevent access to the anterior vertebral ligament, alternative surgical techniques should be discussed per operatively, including colpopexy by lateral mesh laparoscopic suspension, uterosacral ligament suspension, open abdominal mesh surgery, or surgery by the vaginal route (EO)., Bladder Injury: When a bladder injury is diagnosed, bladder repair by suturing is recommended, using a slow resorption suture thread, plus monitoring of the permeability of the ureters (before and after bladder repair) when the injury is located at the level of the trigone (EO). When a bladder injury is diagnosed, after bladder repair, a prosthetic mesh (polypropylene or polyester material) can be placed between the repaired bladder and the vagina, if the quality of the suturing is good. The recommended duration of bladder catheterization following bladder repair in this context of POP mesh surgery is from 5 to 10 days (EO)., Ureter Injury: After ureteral repair, it is possible to continue sacral colpopexy and place the mesh if it is located away from the ureteral repair (EO)., Rectal Injury: Regardless of the approach, when a rectal injury occurs, a posterior mesh should not be placed between the rectum and the vagina wall (EO). Concerning the anterior mesh, it is recommended to use a macroporous monofilament polypropylene mesh (EO). A polyester mesh is not recommended in this situation (EO)., Vaginal Wall Injury: After vaginal wall repair, an anterior or a posterior microporous polypropylene mesh can be placed, if the quality of the repair is found to be satisfactory (EO). A polyester mesh should not be used after vaginal wall repair (EO)., Mesh Infection (abscess, Cellulitis, Spondylodiscitis): Regardless of the surgical approach, intravenous antibiotic prophylaxis is recommended (aminopenicillin + beta-lactamase inhibitor: 30 min before skin incision +/- repeated after 2 h if surgery lasts longer) (EO). When spondylodiscitis is diagnosed following sacral colpopexy, treatment should be discussed by a multidisciplinary group, including especially spine specialists (rheumatologists, orthopedists, neurosurgeons) and infectious disease specialists (EO). When a pelvic abscess occurs following synthetic mesh sacral colpopexy, it is recommended to carry out complete mesh removal as soon as possible, combined with collection of intraoperative bacteriological samples, drainage of the collection and targeted antibiotic therapy (EO). Non-surgical conservative management with antibiotic therapy may be an option (EO) in certain conditions (absence of signs of sepsis, macroporous monofilament polypropylene type 1 mesh, prior microbiological documentation and multidisciplinary consultation for the choice of type and duration of antibiotic therapy), associated with close monitoring of the patient., Bowel Occlusion Related to Non-Closure of the Peritoneum: Peritoneal closure is recommended after placement of a synthetic mesh by the abdominal approach (EO)., Urinary Retention: Preoperative urodynamics is recommended in women presenting with urinary symptoms (bladder outlet obstruction symptoms, overactive bladder syndrome or incontinence) (EO). It is recommended to remove the bladder catheter at the end of the procedure or within 48 h after POP surgery (grade B). Bladder emptying and post-void residual should be checked following POP surgery, before discharge (EO). When postoperative urine retention occurs after POP surgery, it is recommended to carry out indwelling catheterization and to prefer intermittent self-catheterization (EO)., Postoperative Pain: Before POP surgery, the patient should be asked about risk factors for prolonged and chronic postoperative pain (pain sensitization, allodynia, chronic pelvic or non-pelvic pain) (EO). Concerning the prevention of postoperative pain, it is recommended to carry out a pre-, per- and postoperative multimodal pain treatment (grade B). The use of ketamine intraoperatively is recommended for the prevention of chronic postoperative pelvic pain, especially for patients with risk factors (preoperative painful sensitization, allodynia, chronic pelvic or non-pelvic pain) (EO). Postoperative prescription of opioids should be limited in quantity and duration (grade C). When acute neuropathic pain (sciatalgia or pudendal neuralgia) resistant to level I and II analgesics occurs following sacrospinous fixation, a reintervention is recommended for suspension suture removal (EO). When chronic postoperative pain occurs after POP surgery, it is recommended to systematically seek arguments in favor of neuropathic pain with the DN4 questionnaire (EO). When chronic postoperative pelvic pain occurs after POP surgery, central sensitization should be identified since it requires a consultation in a chronic pain department (EO). Concerning myofascial pain syndrome (clinical pain condition associated with increased muscle tension caused by myofascial trigger points), when chronic postoperative pain occurs after POP surgery, it is recommended to examine the levator ani, piriformis and obturator internus muscles, so as to identify trigger points on the pathway of the synthetic mesh (EO). Pelvic floor muscle training with muscle relaxation is recommended when myofascial pain syndrome is associated with chronic postoperative pain following POP surgery (EO). After failure of pelvic floor muscle training (3 months), it is recommended to discuss surgical removal of the synthetic mesh, during a multidisciplinary discussion group meeting (EO). Partial removal of synthetic mesh is indicated when a trigger point is located on the pathway of the mesh (EO). Total removal of synthetic mesh should be discussed during a multidisciplinary discussion group meeting when diffuse (no trigger point) chronic postoperative pain occurs following POP surgery, with or without central sensitization or neuropathic pain syndromes (EO)., Postoperative Dyspareunia: When de novo postoperative dyspareunia occurs after POP surgery, surgical removal of the mesh should be discussed (EO)., Vaginal Mesh Exposure: To reduce the risk of vaginal mesh exposure, when hysterectomy is required during sacral colpopexy, subtotal hysterectomy is recommended (grade C). When asymptomatic vaginal macroporous monofilament polypropylene mesh exposure occurs, systematic imaging is not recommended. When vaginal polyester mesh exposure occurs, pelvic +/- lumbar MRI (EO) should be used to look for an abscess or spondylodiscitis, given the greater risk of infection associated with this type of material. When asymptomatic vaginal mesh exposure of less than 1 cm2 occurs in a woman with no sexual intercourse, the patient should be offered observation (no treatment) or local estrogen therapy (EO). However, if the patient wishes, partial excision of the mesh can be offered. When asymptomatic vaginal mesh exposure of more than 1 cm2 occurs or if the woman has sexual intercourse, or if it is a polyester prosthesis, partial mesh excision, either immediately or after local estrogen therapy, should be offered (EO). When symptomatic vaginal mesh exposure occurs, but without infectious complications, surgical removal of the exposed part of the mesh by the vaginal route is recommended (EO), and not systematic complete excision of the mesh. Following sacral colpopexy, complete removal of the mesh (by laparoscopy or laparotomy) is only required in the presence of an abscess or spondylodiscitis (EO). When vaginal mesh exposure recurs after a first reoperation, the patient should be treated by an experienced team specialized in this type of complication (EO)., Suture Thread Vaginal Exposure: For women presenting with vaginal exposure to non-absorbable suture thread following POP surgery with mesh reinforcement, the suture thread should be removed by the vaginal route (EO). Removal of the surrounding mesh is only recommended when vaginal mesh exposure or associated abscess is diagnosed., Bladder and Ureteral Mesh Exposure: When bladder mesh exposure occurs, removal of the exposed part of the mesh is recommended (grade B). Both alternatives (total or partial mesh removal) should be discussed with the patient and should be debated during a multidisciplinary discussion group meeting (EO)., Competing Interests: Declaration of competing interest The declarations of interests of the experts of the working group were published on the HAS website (https://dpi.sante.gouv.fr )., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
44. Case Report of an exceptional spontaneous abdominal heterotopic pregnancy with superfetation: Diagnosis and treatment: Heterotopic pregnancy with superfetation (8+1 WG & 5+4 WG).
- Author
-
Julien A, Gremeau AS, Campagne-Loiseau S, Chauveau B, Chauvet P, Combet L, and Canis M
- Subjects
- Pregnancy, Female, Humans, Gestational Age, Fertilization, Pregnancy, Heterotopic diagnostic imaging, Pregnancy, Heterotopic surgery, Superfetation, Pregnancy, Abdominal diagnosis, Pregnancy, Abdominal surgery
- Abstract
Heterotopic pregnancy is an extremely rare condition in which an intrauterine and an extrauterine pregnancy co-exist. In spontaneous conceptions, heterotopic pregnancy occurs in only 1/30 000 pregnancies. The treatment of heterotopic pregnancy must be as minimally invasive as possible to preserve the development of the intrauterine pregnancy. Superfetation, defined as the coexistence of 2 or more foetuses of different gestational ages, remains particularly exceptional and poorly explained (second ovulation? embryonic diapause?). Here, we present an extremely rare case of a spontaneous heterotopic evolutive pregnancy with superfetation, consisting of an embryo in the pouch of Douglas estimated at 8 + 1 weeks of gestation (WG) and a progressive intrauterine pregnancy estimated at 5 + 4 WG. We treated the extrauterine pregnancy with an intra-cardiac injection of potassium chloride echo-guided via the vaginal route, and the patient then underwent exploratory laparoscopy 9 days later and lavage and aspiration of the abdominal heterotopic pregnancy due to pain and biological inflammatory syndrome probably caused by pelvic mass syndrome and peritoneal irritation from the foetal necrosis. She has not yet given birth and is currently at 36 WG., Competing Interests: Declaration of Competing Interest The authors declare no conflicts of interest., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
45. Trans-labial or introital ultrasounds for midurethral slings.
- Author
-
Haudebert C, Florin M, Fatton B, Campagne-Loiseau S, and Tse V
- Subjects
- Humans, Adult, Female, Vagina surgery, Urologic Surgical Procedures adverse effects, Urinary Incontinence, Stress diagnostic imaging, Urinary Incontinence, Stress surgery, Suburethral Slings adverse effects, Urinary Incontinence surgery
- Abstract
Stress urinary incontinence is common in adult women. The use of introital or trans-labial ultrasound can help the surgeon (urologist or gynecologist) to better assess the type of incontinence the patient presents in order to guide him in the management of the patient. Often, surgical treatment with a mid-urethral sling (MSU) placement can be chosen in case of failure of non-invasive therapies (such as local estrogen or physical therapy) and if the clinical examination shows an urethral hypermobility. The use of ultrasound can help in this choice. Although rare, complications of MSU can sometimes cause disabling symptoms and be difficult to diagnose. Introital or trans-labial ltrasound can help diagnose them. The objective of this work was to describe the realization of ultrasound of stress urinary incontinence before or after the placement of a MSU, in order to make their realization easier for young surgeons which can use them in current practice., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
46. vNOTEsHC : Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopic for large uteri: study protocol for a multicentre randomised controlled trial.
- Author
-
Druenne J, Presles E, Corsini T, Campagne Loiseau S, Curinier S, Mansour A, Lamblin G, Reboul Q, and Chauleur C
- Abstract
Background: In France, 62,000 hysterectomies are performed per year, 70% of which are benign. The choice of approach (laparotomy, laparoscopy or vaginal route) is particularly important in the case of large uterus (> 280g) which are associated with a higher risk of complications. The current data are not sufficient to favour one or other approach. A new medical device, the vNOTES (Natural Vaginal Orifice Transluminal Endoscopy System), offers the advantage of both laparoscopic and vaginal route for pelvic surgery., Objectives: To demonstrate the superiority in terms of intraoperative and postoperative complications of the use of a natural orifice transluminal endoscopic hysterectomy system (vNOTES) versus laparoscopic hysterectomy for benign pathologies on estimated large volume uteri (>280g)., Materials and Methods: A randomised, double-blind, superiority trial will be performed at five hospital centres. Women with benign uterine pathology requiring hysterectomy and with a large uterus (> 280g) will be randomised to receive either laparoscopic or vNOTES hysterectomy., Main Outcome Measures: The primary outcome will be the occurrence of intraoperative and postoperative complications within 6 weeks of surgery. Secondary outcomes will be conversion during surgery, duration of surgery and hospitalisation, postoperative pain, postoperative complications, resumption of sexual life and satisfaction with the surgical team., Results: 248 women will be randomised., Conclusion: This trial will provide a better understanding of the approach to large uteri optimise the care of these thousands of women undergoing hysterectomy., What’s New?: This trial will evaluate the vNotes for large uteri.
- Published
- 2023
- Full Text
- View/download PDF
47. [Multidisciplinary meetings in pelvic floor disease in women: A national survey by the CUROPF among French urologists].
- Author
-
Dupuis HGA, Berrogain N, Bosset PO, Campagne-Loiseau S, Cardot V, Charles T, Deffieux X, Donon L, Even L, Girard F, Hermieu JF, Hurel S, Klap J, Peyrat L, Meyer F, Peyronnet B, Tibi B, Thuillier C, Vidart A, Wagner L, and Cornu JN
- Subjects
- Humans, Female, Urologists, France, Pelvic Floor Disorders therapy, Suburethral Slings
- Abstract
Introduction: Multidisciplinary team meetings (MTMs) in the field of pelvic floor diseases in women tend to generalize, as they are required as mandatory before mid-urethral sling implantation or sacrocolpopexy by recent decrees published by the French health authorities. However, access to these meetings is variable in the French territory. The goal of the present study was to describe the existence and the settings of these kinds of meetings in France., Materiel and Methods: An on-line survey was conducted between June and July 2020 (stage 1) then between November 2021 and January 2022 (stage 2). A 15-item questionnaire was sent to all members of the Association française d'urologie (AFU). A descriptive analysis was conducted., Results: Three hundred and twenty-two completed questionnaires were sent back during stage 1 and 158 during stage 2. Early 2022, 61.3% of respondents had access to a pelviperineology MTM, with important difference according to geographical areas. Main activity of MTMs was case discussion of complex situations (68% of meetings). At the end of 2021, 22% of the respondents declared willing to stop partially or totally their pelviperineology activity, given the new regulations set in place by the authorities., Conclusion: Despite being absolutely mandatory in current clinical practice, MTMs in pelvic floor disease have spread slowly. MTMs implementation was still insufficient in 2022, and variable on the French territory. Some urologists declare having no access to such resources and about 1 out of 5 were considering to voluntary stop of decrease significantly their activity in this difficult context., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
48. Do Surgeons Anticipate Women's Hopes and Fears Associated with Prolapse Repair? A Qualitative Analysis in the PROSPERE Trial.
- Author
-
Fritel X, Ravit M, Pizzoferrato AC, Campagne-Loiseau S, Bader G, Capmas P, Cosson M, Debodinance P, Deffieux X, Fernandez H, Ferry P, Garbin O, Jacquetin B, Legendre G, Saussine C, de Tayrac R, Wagner L, Lucot JP, Fauconnier A, and The Prospere Team
- Abstract
Women's preoperative perceptions of pelvic-floor disorders may differ from those of their physicians. Our objective was to specify women's hopes and fears before cystocele repair, and to compare them to those that surgeons anticipate. We performed a secondary qualitative analysis of data from the PROSPERE trial. Among the 265 women included, 98% reported at least one hope and 86% one fear before surgery. Sixteen surgeons also completed the free expectations-questionnaire as a typical patient would. Women's hopes covered seven themes, and women's fears eleven. Women's hopes were concerning prolapse repair (60%), improvement of urinary function (39%), capacity for physical activities (28%), sexual function (27%), well-being (25%), and end of pain or heaviness (19%). Women's fears were concerning prolapse relapse (38%), perioperative concerns (28%), urinary disorders (26%), pain (19%), sexual problems (10%), and physical impairment (6%). Surgeons anticipated typical hopes and fears which were very similar to those the majority of women reported. However, only 60% of the women reported prolapse repair as an expectation. Women's expectations appear reasonable and consistent with the scientific literature on the improvement and the risk of relapse or complication related to cystocele repair. Our analysis encourages surgeons to consider individual woman's expectations before pelvic-floor repair.
- Published
- 2023
- Full Text
- View/download PDF
49. Serious Complications and Recurrence following Sacrospinous Ligament Fixation for the Correction of Apical Prolapse.
- Author
-
De Gracia S, Fatton B, Cosson M, Campagne-Loiseau S, Ferry P, Lucot JP, Debodinance P, Panel L, Deffieux X, Garbin O, Lamblin G, Carlier-Guérin C, Ramanah R, Fauconnier A, Serrand C, Fritel X, and de Tayrac R
- Abstract
Objective: To evaluate the rates of serious complications and reoperation for recurrence following sacrospinous ligament fixation (SSLF) for apical pelvic organ prolapse. Methods: This was a national registry ancillary cohort comparative study. The VIGI-MESH registry includes data from 24 French health centers prospectively collected between May 2017 and September 2021. Time to occurrence of a serious complication or reoperation for genital prolapse recurrence was explored using the Kaplan-Meier curve and Log-rank test. The inverse probability of treatment weighting, based on propensity scores, was used to adjust for between-group differences. Results: A total of 1359 women were included and four surgical groups were analyzed: Anterior SSLF with mesh (n = 566), Anterior SSLF with native tissue (n = 331), Posterior SSLF with mesh (n = 57), and Posterior SSLF with native tissue (n = 405). Clavien-Dindo Grade III complications or higher were reported in 34 (2.5%) cases, with no statistically significant differences between the groups. Pelvic organ prolapse recurrence requiring re-operation was reported in 44 (3.2%) women, this was higher following posterior compared with anterior SSLF ( p = 0.0034). Conclusions: According to this large database ancillary study, sacrospinous ligament fixation is an effective and safe surgical treatment for apical prolapse. The different surgical approaches (anterior/posterior and with/without mesh) have comparable safety profiles. However, the anterior approach and the use of mesh were associated with a lower risk of reoperation for recurrence compared with the posterior approach and the use of native tissue, respectively.
- Published
- 2023
- Full Text
- View/download PDF
50. [Intravesical instillations for inflammatory and sensory chronic bladder diseases: Literature review and guide to clinical practice].
- Author
-
Meyer F, Chen É, Berrogain N, Bosset PO, Campagne-Loiseau S, Cardot V, Charles T, Deffieux X, Donon L, Even L, Girard F, Hermieu JF, Hurel S, Klap J, Peyrat L, Thuillier C, Tibi B, Vidart A, Wagner L, and Cornu JN
- Subjects
- Administration, Intravesical, Chronic Disease, Female, Glycosaminoglycans therapeutic use, Humans, Male, Quality of Life, Cystitis drug therapy, Cystitis, Interstitial drug therapy
- Abstract
Introduction: Inflammatory and sensory chronic bladder diseases have a significant impact on quality of life. These pathologies share alteration of the layer between urine and urothelium, making the use of topical agents appropriate., Objectives: Review the efficacy and tolerance of intravesical treatments for these pathologies. Give practical guidelines for the use of agents currently available in France., Method: A narrative review was performed in March 2021 using PubMed/MEDLINE, Google Scholar and the international guidelines. Pharmaceutical companies and pharmacies were interviewed., Results: Although numerous molecules were tested over the last 5 decades, only dimethylsulfoxyde and glycosaminoglycans are available in France today. Results are promising: response rates are up to 95% and 84% respectively in bladder pain syndrome. In urinary tract infections, glycosaminoglycans could decrease annual number of cystitis by 2.56 (95% confidence interval (CI) -3.86, -1.26; P<0.001) and increase the time to first cystitis recurrence by 130 days (95% CI: 5.84 - 254.26; P=0.04). In radiation cystitis, results could be comparable to hyperbaric oxygen regarding pain and frequency of voiding (-1.31±1.3 visual analogic scale et -1.5±1.4 voiding per day, respectively, at 12 months, P<0.01). However, literature has a low level of evidence., Conclusion: Chronic bladder diseases have limited treatment options. Intravesical agents are a good alternative, although their cost is significant and their outcome uncertain., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.